Suppr超能文献

单次注射链脲佐菌素后,巴比妥钠诱导的肾病及再生性肾小管增生的改善并不能消除巴比妥钠对雄性F344/NC4大鼠的肾肿瘤促进作用。

Amelioration of sodium barbital-induced nephropathy and regenerative tubular hyperplasia after a single injection of streptozotocin does not abolish the renal tumor promoting effect of barbital sodium in male F344/NC4 rats.

作者信息

Konishi N, Diwan B A, Ward J M

机构信息

Tumor Pathology and Pathogenesis Section, National Cancer Institute, Frederick, MD 21702-1201.

出版信息

Carcinogenesis. 1990 Dec;11(12):2149-56. doi: 10.1093/carcin/11.12.2149.

Abstract

The renal tumor promoting activity of barbital sodium (BBNa) and the role of renal tubular cell hyperplasia in tumor promotion following initiation with streptozotocin (STZ) was investigated. Six week old male F344/NCr rats were given STZ as a single i.p. injection of 50 mg/kg body wt and beginning 2 weeks later were fed diets containing 0 or 4000 p.p.m. of BBNa until they were killed at 33, 52 or 72 experimental weeks for histological evaluation and determination of levels of renal DNA synthesis by bromodeoxyuridine (Brdu) immunohistochemistry. A promoting effect on renal carcinogenesis was found by 72 weeks, but not at 33 or 52 weeks, confirming that prolonged administration of BBNa is necessary to promote renal tubular cell neoplasms. The promoting effect was evident as a higher incidence of large renal tubular tumors after 52 weeks, rather than an increase in number of dysplastic tubules, putative preneoplastic lesions. These findings suggest that the targets for the promoting activity of BBNa may be dysplastic lesions which may progress to tumors. Detailed examination by the step section technique through the entire kidneys revealed that STZ or BBNa administration induced a high incidence of putative preneoplastic renal tubular lesions (dysplasias) which seemed to be derived from the P1 or P2 segment of the nephron, also a site of high Brdu labeling index (LI) associated with BBNa toxicity. STZ administration was also associated with attenuation of BBNa-induced nephropathy and with diabetes from pancreatic islet degeneration and atrophy. The reduction in severity of nephropathy was correlated with a reduction in the LI of the renal cortical and medullary tubules, but not with the renal tumor incidence. These results indicate that decreased DNA synthesis in target cells does not eliminate tumor promoting activity in renal tubular epithelium. In addition, BBNa alone induced papillomas of the transitional epithelium of the renal pelvis and renal tubular cell adenomas.

摘要

研究了巴比妥钠(BBNa)的肾肿瘤促进活性以及肾小管细胞增生在链脲佐菌素(STZ)启动后的肿瘤促进中的作用。六周龄雄性F344/NCr大鼠单次腹腔注射50mg/kg体重的STZ,两周后开始喂食含0或4000ppm BBNa的饲料,直至在实验第33、52或72周处死,进行组织学评估并通过溴脱氧尿苷(Brdu)免疫组化测定肾DNA合成水平。在72周时发现对肾癌发生有促进作用,但在33或52周时未发现,证实长期给予BBNa对促进肾小管细胞瘤是必要的。促进作用表现为52周后大肾小管肿瘤的发生率更高,而不是发育异常小管(假定的癌前病变)数量增加。这些发现表明,BBNa促进活性的靶点可能是可能进展为肿瘤的发育异常病变。通过对整个肾脏进行连续切片技术的详细检查发现,给予STZ或BBNa会导致假定的癌前肾小管病变(发育异常)的高发生率,这些病变似乎源自肾单位的P1或P2段,也是与BBNa毒性相关的高Brdu标记指数(LI)的部位。给予STZ还与BBNa诱导的肾病减轻以及胰岛退变和萎缩导致的糖尿病有关。肾病严重程度的降低与肾皮质和髓质小管LI的降低相关,但与肾肿瘤发生率无关。这些结果表明,靶细胞中DNA合成的减少并不能消除肾小管上皮中的肿瘤促进活性。此外,单独给予BBNa会诱导肾盂移行上皮乳头状瘤和肾小管细胞腺瘤。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验